Centre for Genomic and Experimental Medicine

Centre for Genomic and Experimental Medicine
Name	Centre for Genomic and Experimental Medicine
Established	1990s
Type	Research institute
City	Edinburgh
Country	Scotland
Parent	University of Edinburgh
Director	David J. Porteous

Centre for Genomic and Experimental Medicine.

The Centre for Genomic and Experimental Medicine is a biomedical research institute within the University of Edinburgh focused on human genetics, molecular medicine, and translational science. It connects clinical practice at Royal Infirmary of Edinburgh with basic science linking to initiatives such as the UK Biobank, the Human Genome Project, and collaborations with the Wellcome Trust. The Centre works alongside institutions including NHS Scotland, Medical Research Council, and international partners like the National Institutes of Health and the European Molecular Biology Laboratory.

History

The Centre was formed during a period marked by the rise of large-scale projects such as the Human Genome Project and the expansion of genomic medicine championed by figures like Craig Venter and institutions such as the Wellcome Sanger Institute. Its foundation aligned with strategic developments at the University of Edinburgh and the Scottish Parliament's support for biomedical research in Edinburgh. Early collaborations included partnerships with the Medical Research Council (UK) and networks connected to the European Research Council and the NIHR. Over time the Centre engaged with consortia including the 100,000 Genomes Project and multi-center studies with the Broad Institute and the Max Planck Society.

Research Areas

Research spans human genetics, genomic epidemiology, and experimental models integrating approaches from labs such as Wellcome Centre for Human Genetics and groups influenced by the work of Mary-Claire King and Eric Lander. Major themes include genomic variation studies that reference datasets like the 1000 Genomes Project and the UK Biobank, rare disease genetics in the tradition of Victor McKusick, and polygenic risk research comparable to efforts at the Broad Institute and Karolinska Institute. Functional genomics projects use technologies developed by teams associated with Illumina, Oxford Nanopore Technologies, and methodologies from CRISPR-Cas9 developers including Jennifer Doudna and Emmanuelle Charpentier. Translational programs interface with clinical genetics services modeled on Mayo Clinic and Johns Hopkins Medicine approaches.

Facilities and Resources

Facilities include sequencing platforms comparable to those used by the Wellcome Sanger Institute and core services resembling infrastructures at the European Bioinformatics Institute and EMBL-EBI. The Centre houses bioinformatics pipelines informed by standards from the GA4GH and computational collaborations with groups at EPCC and the Alan Turing Institute. Laboratory resources support model organism work reflecting protocols from Jackson Laboratory and cellular phenotyping capabilities aligned with technologies from Flow Cytometry Facility models at the Max Delbrück Center. Biobanking and sample management correspond to practices from UK Biobank and regional NHS biorepositories.

Academic and Clinical Collaborations

The Centre maintains academic links across the University of Edinburgh including the Roslin Institute and the Usher Institute and clinical partnerships with NHS Lothian and specialty services at the Royal Hospital for Children and Young People. International research ties extend to the National Institutes of Health, the European Molecular Biology Laboratory, and university partners such as University of Oxford, University of Cambridge, Harvard University, Stanford University, Karolinska Institute, and McGill University. Collaborative consortia include participation in projects led by the International Cancer Genome Consortium and the Global Alliance for Genomics and Health.

Funding and Governance

Funding sources include competitive awards from the Wellcome Trust, grants from the Medical Research Council (UK), program support from the National Institute for Health and Care Research, and philanthropic contributions akin to donations received by institutions such as the Gates Foundation and the Cancer Research UK. Governance frameworks are aligned with university oversight at the University of Edinburgh and regulatory standards from bodies like the Human Tissue Authority and research ethics structures similar to those of the UK Research Integrity Office.

Notable Achievements and Awards

Notable achievements feature contributions to rare disease gene discovery resonant with breakthroughs credited to Mary-Claire King and pathway elucidation parallel to studies at the Broad Institute and the Wellcome Sanger Institute. The Centre's work has been recognized by major funders including Wellcome Trust awards, MRC programme grants, and honours comparable to institutional recognition by the Royal Society of Edinburgh. Collaborative outputs have influenced national initiatives such as the 100,000 Genomes Project and informed NHS genomic medicine roll-outs led by Genomics England.

Category:Biomedical research institutes Category:University of Edinburgh